HHS Secretary Alex Azar reaffirmed that drug rebate changes are coming, during an address at the FT Pharma Pricing and Value Summit Sept. 13, but he did not mention eliminating discounts altogether.
The pharmaceutical industry is in a whirlwind about rebates, preparing for a future that is expected to include big changes to the long-standing practice industry relies on to negotiate market...